Dali Pharmaceuticalco.,Ltd (603963.SS)
CNY 1.18
(0.0%)
CNY 1.18
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.09 CNY | -11.66% |
| 2022 | -0.08 CNY | 57.58% |
| 2021 | -0.19 CNY | -1392.52% |
| 2020 | 0.01 CNY | -76.1% |
| 2019 | 0.06 CNY | 33.12% |
| 2018 | 0.05 CNY | -84.6% |
| 2017 | 0.30 CNY | -21.05% |
| 2016 | 0.38 CNY | -17.39% |
| 2015 | 0.46 CNY | -49.45% |
| 2014 | 0.91 CNY | 8.33% |
| 2013 | 0.84 CNY | -2.33% |
| 2012 | 0.86 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.03 CNY | -26.12% |
| 2024 Q3 | -0.03 CNY | -11.65% |
| 2024 Q1 | -0.02 CNY | -18.93% |
| 2023 Q4 | -0.02 CNY | 1.9% |
| 2023 FY | - CNY | -11.66% |
| 2023 Q1 | -0.01 CNY | 59.01% |
| 2023 Q2 | -0.04 CNY | -223.28% |
| 2023 Q3 | -0.02 CNY | 44.0% |
| 2022 Q3 | -0.01 CNY | 43.33% |
| 2022 Q2 | -0.02 CNY | -64.38% |
| 2022 Q1 | -0.01 CNY | 90.88% |
| 2022 FY | - CNY | 57.58% |
| 2022 Q4 | -0.03 CNY | -108.09% |
| 2021 Q2 | -0.01 CNY | -822.22% |
| 2021 FY | - CNY | -1392.52% |
| 2021 Q4 | -0.16 CNY | -604.85% |
| 2021 Q1 | 0.00 CNY | 112.33% |
| 2021 Q3 | -0.02 CNY | -249.23% |
| 2020 Q4 | -0.01 CNY | -137.44% |
| 2020 FY | - CNY | -76.1% |
| 2020 Q1 | -0.01 CNY | 32.0% |
| 2020 Q2 | 0.01 CNY | 323.53% |
| 2020 Q3 | 0.02 CNY | 71.05% |
| 2019 FY | - CNY | 33.12% |
| 2019 Q4 | -0.01 CNY | -166.37% |
| 2019 Q3 | 0.01 CNY | -51.29% |
| 2019 Q2 | 0.02 CNY | -24.68% |
| 2019 Q1 | 0.03 CNY | 48.08% |
| 2018 Q3 | 0.02 CNY | 141.85% |
| 2018 Q4 | 0.02 CNY | 35.06% |
| 2018 Q1 | 0.04 CNY | 31.43% |
| 2018 FY | - CNY | -84.6% |
| 2018 Q2 | -0.04 CNY | -188.89% |
| 2017 Q2 | 0.08 CNY | -30.55% |
| 2017 Q3 | 0.06 CNY | -22.51% |
| 2017 Q4 | 0.03 CNY | -46.79% |
| 2017 FY | - CNY | -21.05% |
| 2017 Q1 | 0.11 CNY | -31.25% |
| 2016 FY | - CNY | -17.39% |
| 2016 Q4 | 0.16 CNY | 151.18% |
| 2016 Q3 | 0.06 CNY | 0.0% |
| 2015 Q1 | 0.12 CNY | 0.0% |
| 2015 Q2 | 0.12 CNY | 0.0% |
| 2015 FY | - CNY | -49.45% |
| 2014 FY | - CNY | 8.33% |
| 2013 FY | - CNY | -2.33% |
| 2012 FY | - CNY | 0.0% |